Replies to post #510718 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Rightly so. Conferences don’t normally allow new abstracts that were already presented at another conference, so logically, one would assume her abstract will have follow up data and/or secondary endpoint data.